Regulation of hepatocarcinogenesis by microRNAs

Chun-Ming Wong1, Alan Ka-Lun Kai, Felice Ho-Ching Tsang

  • 1Department of Pathology, University Pathology Building, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong.

Insights

MicroRNAs (miRNAs) are key in liver cancer (hepatocellular carcinoma, HCC) development. This review explores aberrant miRNA expression, their roles in HCC, and potential clinical applications for diagnosis and therapy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a significant global cancer, often linked to HBV and HCV infections.
  • The molecular mechanisms driving hepatocarcinogenesis remain incompletely understood.
  • MicroRNAs (miRNAs), small non-coding RNAs regulating gene expression, are increasingly recognized for their role in cancer.

Purpose of the Study:

  • To review the aberrant expression of miRNAs in liver cancer.
  • To discuss the pathological implications and molecular functions of key oncogenic and tumor-suppressive miRNAs in HCC.
  • To explore the potential of miRNAs as diagnostic and therapeutic agents for liver cancer.

Main Methods:

  • Literature review focusing on microRNA deregulation in hepatocellular carcinoma.
  • Analysis of studies investigating the roles of specific oncogenic and tumor-suppressive miRNAs.
  • Examination of current research on miRNA-based diagnostics and therapeutics.

Main Results:

  • MicroRNA expression patterns are significantly altered in liver cancer.
  • Specific miRNAs function as oncogenes or tumor suppressors, influencing HCC progression.
  • Deregulation of miRNAs is a common feature across various stages of hepatocarcinogenesis.

Conclusions:

  • Aberrant miRNA expression is integral to liver cancer pathogenesis.
  • Understanding miRNA functions offers insights into molecular mechanisms of HCC.
  • miRNAs hold promise for novel diagnostic markers and therapeutic strategies in liver cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...